Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens Journal Article


Authors: Ayala, G. E.; Muezzinoglu, B.; Hammerich, K. H.; Frolov, A.; Liu, H.; Scardino, P. T.; Li, R.; Sayeeduddin, M.; Ittmann, M. M.; Kadmon, D.; Miles, B. J.; Wheeler, T. M.; Rowley, D. R.
Article Title: Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens
Abstract: We previously reported that reactive stroma grading in prostate cancer (PCa) is predictive of biochemical recurrence in prostatectomies and biopsies. In this study, we tested whether quantifying the percentage of reactive stromal grade 3 (RSG 3; stromogenic carcinoma pattern) in the entire tumor is predictive of PCa-specific death. Whole-mount prostatectomies operated by a single surgeon obtained between 1983 and 1998 were reviewed. Reactive stroma was evaluated as described previously, and areas of RSG 3 in the entire tumor were registered as percentages of total tumor. Statistical analysis was performed using Spearman, Kaplan-Meier, and Cox analyses. In all, 872 cases were evaluable. Quantification of RSG 3 percentage was an independent predictor of biochemical recurrence, analyzed as a continuous or grouped variable. Patients with higher RSG 3 percentages (larger tumor areas with RSG 3) had a significantly decreased biochemical recurrence-free survival than those with a lower RSG 3 percentage, even within the Gleason score 7 subset of patients. A nomogram introduced this new variable to the model. Furthermore, quantification of RSG 3 percentage was significantly predictive of PCa-specific death. Quantification of the RSG 3 (stromogenic carcinoma) area in PCa provides additional novel information on prognosis. These data substantiate the concept that the tumor microenvironment holds significant predictive information, as well as biological significance. Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Keywords: human tissue; major clinical study; histopathology; cancer recurrence; outcome assessment; follow up; cancer grading; prostate specific antigen; progression free survival; cancer mortality; prostate cancer; gleason score; correlation coefficient; proportional hazards model; prostatectomy; stroma; kaplan meier method; nomogram; reactive stromal grade 3; tumor microenvironment
Journal Title: American Journal of Pathology
Volume: 178
Issue: 1
ISSN: 0002-9440
Publisher: Elsevier Science, Inc.  
Date Published: 2011-01-01
Start Page: 79
End Page: 87
Language: English
DOI: 10.1016/j.ajpath.2010.09.042
PROVIDER: scopus
PMCID: PMC3069909
PUBMED: 21224046
DOI/URL:
Notes: --- - "Export Date: 4 March 2011" - "CODEN: AJPAA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Peter T Scardino
    671 Scardino